(888) 635 - 2250
Nothing on this site should be taken as legal advice for any individual case or situation. Every claim and potential legal claim must be viewed on its own merits. The information on this website is for general information purposes only. It is not intended to create, and receipt or viewing of this information does not constitute, an attorney-client relationship. Every situation and every client’s legal matter is different and this website is merely meant to provide information to the public. Nor does this website create an attorney-client relationship – such a relationship has not been formed unless a signed fee agreement has been made. If you want legal advice or want to know if you have suffered a legal wrong contact the attorneys at The Law Office of Hakimi & Shahriari at (888) 635 - 2250.
If you or a loved one have noticed unnatural development of breast tissue as a boy or young man, you may be one of the many people entitled to compensation from the drug manufacturers through a legal claim. Depending on your individual claim, you may be able to collect compensation for medical bills (past, present, and future), pain and suffering, loss of wages, emotional and psychological distress, and other damages. If you believe your condition is a result of using Risperdal, please contact our firm immediately for a free consultation as there may be a statute of limitations on your claim, depending on your jurisdiction.
HAVE YOU OR A LOVED ONE DEVELOPED ABNORMAL MALE BREAST TISSUE (GYNECOMASTIA) AFTER USING THE ANTIPSYCHOTIC MEDICATION KNOWN AS RISPERDAL? PLEASE CALL OUR FIRM AT (888) 635 - 2250 FOR A FREE CONSULTATION.
About the Health Risks of Risperdal
Risperdal (risperidone) is an antipsychotic medicine approved by the U.S. Food and Drug Administration (FDA) that works by changing the effects of chemicals in the brain. It is used to treat schizophrenia, symptoms of bipolar disorder, otherwise known as manic depression, as well as symptoms of irritability in autistic children. Manufacturers of the drug, Johnson & Johnson, through its subsidiary Janssen Pharmaceuticals, promoted the drug for young people to treat a variety of mental health and behavioral issues before it was approved for limited use in children in 2007, and without adequate labeling the drug to warn consumers of the adverse side effects and risks of gynecomastia. Additionally, Johnson & Johnson did not relabel the drug to warn of its adverse effects, even after doctors and professionals from the medical community advised them to do so.
Studies were conducted to test the side effects of the drug in boys and young men; unfortunately, many of the studies showed that boys and young men who used Risperdal developed a condition known as gynecomastia, which is characterized by the increase and unnatural growth of breast tissue within males. It has been alleged that the boys and young men who have taken Risperdal have increased levels of prolactin, the hormone that stimulates breast, not fat, tissue. Other side effects exhibited by the studies showed increased feelings of loneliness, pain, tension, restlessness, and eating disorders. Overall, the studies showed that use of the drug had a devastating impact on the emotional and psychological well-being of the patients. Notably, many of the lawsuits have alleged that Janssen Pharmaceuticals and Johnson & Johnson were aware of the dangerous risks of Risperdal use when the FDA approved the drug in the early 1990’s.
ATTORNEY ADVERTISING - THE LAW OFFICE OF HAKIMI & SHAHRIARI
The Law Office of Hakimi & Shahriari
1800 Vine Street
Los Angeles, California 90028
Toll-Free: (888) 635 - 2250
Fax: (213) 402 - 2170